Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Meyer

Showing results (101-110 of 117) with videos related to

Pageof 12
Sort By:
BMJ Open|November 13, 2020
Efficacy of pragmatic same-day ring prophylaxis for adult individuals exposed to SARS-CoV-2 in Switzerland (COPEP): protocol of an open-label cluster randomised trialMikaela Smit, Annalisa Marinosci, Giovanni Jacopo Nicoletti, et al.
Mbio|December 13, 2012
Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell linesMarcel A Müller, V Stalin Raj, Doreen Muth, et al.
The Lancet. Infectious Diseases|May 27, 2015
Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological studyMarcel A Müller, Benjamin Meyer, Victor M Corman, et al.
The Lancet. Infectious Diseases|April 13, 2015
Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological studyMarcel A Müller, Benjamin Meyer, Victor M Corman, et al.
Nature Communications|January 30, 2023
Influence of circadian clocks on adaptive immunity and vaccination responsesLouise Madeleine Ince, Coline Barnoud, Lydia Kay Lutes, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 17, 2016
Link of a ubiquitous human coronavirus to dromedary camelsVictor M Corman, Isabella Eckerle, Ziad A Memish, et al.
Lancet (London, England)|June 15, 2020
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based studySilvia Stringhini, Ania Wisniak, Giovanni Piumatti, et al.
Emerging Infectious Diseases|April 30, 2013
Human betacoronavirus 2c EMC/2012-related viruses in bats, Ghana and EuropeAugustina Annan, Heather J Baldwin, Victor Max Corman, et al.
Eclinicalmedicine|November 15, 2021
Post-exposure Lopinavir-Ritonavir Prophylaxis versus Surveillance for Individuals Exposed to SARS-CoV-2: The COPEP Pragmatic Open-Label, Cluster Randomized TrialNiklaus D Labhardt, Mikaela Smit, Ianis Petignat, et al.
The Lancet. Infectious Diseases|August 13, 2013
Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological studyChantal B E M Reusken, Bart L Haagmans, Marcel A Müller, et al.
Pageof 12

Showing results (101-110 of 117) with videos related to

Sort By:
Pageof 12
BMJ Open|November 13, 2020
Efficacy of pragmatic same-day ring prophylaxis for adult individuals exposed to SARS-CoV-2 in Switzerland (COPEP): protocol of an open-label cluster randomised trialMikaela Smit, Annalisa Marinosci, Giovanni Jacopo Nicoletti, et al.
Mbio|December 13, 2012
Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell linesMarcel A Müller, V Stalin Raj, Doreen Muth, et al.
The Lancet. Infectious Diseases|May 27, 2015
Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological studyMarcel A Müller, Benjamin Meyer, Victor M Corman, et al.
The Lancet. Infectious Diseases|April 13, 2015
Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological studyMarcel A Müller, Benjamin Meyer, Victor M Corman, et al.
Nature Communications|January 30, 2023
Influence of circadian clocks on adaptive immunity and vaccination responsesLouise Madeleine Ince, Coline Barnoud, Lydia Kay Lutes, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 17, 2016
Link of a ubiquitous human coronavirus to dromedary camelsVictor M Corman, Isabella Eckerle, Ziad A Memish, et al.
Lancet (London, England)|June 15, 2020
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based studySilvia Stringhini, Ania Wisniak, Giovanni Piumatti, et al.
Emerging Infectious Diseases|April 30, 2013
Human betacoronavirus 2c EMC/2012-related viruses in bats, Ghana and EuropeAugustina Annan, Heather J Baldwin, Victor Max Corman, et al.
Eclinicalmedicine|November 15, 2021
Post-exposure Lopinavir-Ritonavir Prophylaxis versus Surveillance for Individuals Exposed to SARS-CoV-2: The COPEP Pragmatic Open-Label, Cluster Randomized TrialNiklaus D Labhardt, Mikaela Smit, Ianis Petignat, et al.
The Lancet. Infectious Diseases|August 13, 2013
Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological studyChantal B E M Reusken, Bart L Haagmans, Marcel A Müller, et al.
Pageof 12